 WOBURN, Mass., Nov. 23, 2021 GLOBE NEWSWIRE -- Biofrontera Inc. Nasdaq: BFRI, a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three and nine months ended September 30, 2021 before the opening of the U.S. financial markets on Tuesday, November 30, 2021 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time to discuss those results and provide a business update. 